Cargando…
3D bioprinting in cardiac tissue engineering
Heart disease is the main cause of death worldwide. Because death of the myocardium is irreversible, it remains a significant clinical challenge to rescue myocardial deficiency. Cardiac tissue engineering (CTE) is a promising strategy for repairing heart defects and offers platforms for studying car...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315053/ https://www.ncbi.nlm.nih.gov/pubmed/34335973 http://dx.doi.org/10.7150/thno.61621 |
_version_ | 1783729659951710208 |
---|---|
author | Wang, Zihan Wang, Ling Li, Ting Liu, Sitian Guo, Baolin Huang, Wenhua Wu, Yaobin |
author_facet | Wang, Zihan Wang, Ling Li, Ting Liu, Sitian Guo, Baolin Huang, Wenhua Wu, Yaobin |
author_sort | Wang, Zihan |
collection | PubMed |
description | Heart disease is the main cause of death worldwide. Because death of the myocardium is irreversible, it remains a significant clinical challenge to rescue myocardial deficiency. Cardiac tissue engineering (CTE) is a promising strategy for repairing heart defects and offers platforms for studying cardiac tissue. Numerous achievements have been made in CTE in the past decades based on various advanced engineering approaches. 3D bioprinting has attracted much attention due to its ability to integrate multiple cells within printed scaffolds with complex 3D structures, and many advancements in bioprinted CTE have been reported recently. Herein, we review the recent progress in 3D bioprinting for CTE. After a brief overview of CTE with conventional methods, the current 3D printing strategies are discussed. Bioink formulations based on various biomaterials are introduced, and strategies utilizing composite bioinks are further discussed. Moreover, several applications including heart patches, tissue-engineered cardiac muscle, and other bionic structures created via 3D bioprinting are summarized. Finally, we discuss several crucial challenges and present our perspective on 3D bioprinting techniques in the field of CTE. |
format | Online Article Text |
id | pubmed-8315053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-83150532021-07-30 3D bioprinting in cardiac tissue engineering Wang, Zihan Wang, Ling Li, Ting Liu, Sitian Guo, Baolin Huang, Wenhua Wu, Yaobin Theranostics Review Heart disease is the main cause of death worldwide. Because death of the myocardium is irreversible, it remains a significant clinical challenge to rescue myocardial deficiency. Cardiac tissue engineering (CTE) is a promising strategy for repairing heart defects and offers platforms for studying cardiac tissue. Numerous achievements have been made in CTE in the past decades based on various advanced engineering approaches. 3D bioprinting has attracted much attention due to its ability to integrate multiple cells within printed scaffolds with complex 3D structures, and many advancements in bioprinted CTE have been reported recently. Herein, we review the recent progress in 3D bioprinting for CTE. After a brief overview of CTE with conventional methods, the current 3D printing strategies are discussed. Bioink formulations based on various biomaterials are introduced, and strategies utilizing composite bioinks are further discussed. Moreover, several applications including heart patches, tissue-engineered cardiac muscle, and other bionic structures created via 3D bioprinting are summarized. Finally, we discuss several crucial challenges and present our perspective on 3D bioprinting techniques in the field of CTE. Ivyspring International Publisher 2021-07-06 /pmc/articles/PMC8315053/ /pubmed/34335973 http://dx.doi.org/10.7150/thno.61621 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Review Wang, Zihan Wang, Ling Li, Ting Liu, Sitian Guo, Baolin Huang, Wenhua Wu, Yaobin 3D bioprinting in cardiac tissue engineering |
title | 3D bioprinting in cardiac tissue engineering |
title_full | 3D bioprinting in cardiac tissue engineering |
title_fullStr | 3D bioprinting in cardiac tissue engineering |
title_full_unstemmed | 3D bioprinting in cardiac tissue engineering |
title_short | 3D bioprinting in cardiac tissue engineering |
title_sort | 3d bioprinting in cardiac tissue engineering |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315053/ https://www.ncbi.nlm.nih.gov/pubmed/34335973 http://dx.doi.org/10.7150/thno.61621 |
work_keys_str_mv | AT wangzihan 3dbioprintingincardiactissueengineering AT wangling 3dbioprintingincardiactissueengineering AT liting 3dbioprintingincardiactissueengineering AT liusitian 3dbioprintingincardiactissueengineering AT guobaolin 3dbioprintingincardiactissueengineering AT huangwenhua 3dbioprintingincardiactissueengineering AT wuyaobin 3dbioprintingincardiactissueengineering |